Cardiovascular and health indicators
Beyond weight loss: can inflammation markers improve?
The new study observed a decrease in inflammation markers, but interpretation requires looking at the underlying diseases of the participants.
Weight loss is not just about kilograms. However, an improvement in a blood test cannot be directly translated into a reduction in your personal risk of heart disease.
Who is the study looking at?
SELECT included 17,604 overweight or obese adults with existing atherosclerotic cardiovascular disease but without diabetes. This analysis focused on high-sensitivity C-reactive protein (hsCRP), an indicator of inflammation.
After using semaglutide, the indicators decreased
The study observed a decrease in hsCRP in the semaglutide group, and some of the changes preceded substantial weight loss. This led the researchers to further explore whether changes in inflammation, in addition to weight loss, may also be involved in cardiovascular benefits.
What are the limitations of this study?
This was a secondary analysis of the original trial, and changes in metrics alone cannot prove the cause of cardiovascular benefit. Nor can the percentage reduction in hsCRP be regarded as a percentage reduction in heart disease risk, or be directly applied to all weight losers without cardiovascular disease.
During the follow-up visit, blood pressure, blood lipids and blood sugar should also be assessed
In addition to weight, you can also review blood pressure, blood lipids, blood sugar, and past medical history with your doctor. Whether additional tests are needed depends on individual circumstances; there is no need to add tests or change original cardiovascular medications just because you read this study.
In addition to weight, what are the health indicators that I need to track most right now? Does this study relate to my medical history?
Original document
This article summarizes research results and care reminders and cannot replace individual diagnosis and treatment. The drugs or uses under study may not have been approved in Taiwan. Please do not change the medication or adjust the dosage accordingly.